dawnpowell

15 POSTS 0 COMMENTS

Abiomed invests $15 million in Shockwave Medical

A press release reports that Abiomed is to invest US$15 million in Shockwave Medical and the two companies will collaborate on a training and...

US FDA plan shakeup of its 510(k) clearance programme

The US FDA has announced plans to modernise its 510(k) clearance programme for approving medical devices for the US market. Data show that about...

The resurgence of renal denervation

More than ever before, arterial hypertension represents one of the greatest health threats and challenges for both patients and treating physicians. With the new...

US FDA approve new study of Medtronic’s Spyral renal denervation system

The FDA have given Medtronic approval to begin a clinical trial to evaluate the Symplicity Spyral renal denervation system in patients with hypertension who...

First patients enrolled in trial of MobiusHD for drug-resistant hypertension

Vascular Dynamics has revealed that enrolment of the first patients in an FDA-approved and best-in-class pivotal clinical trial has started. The CALM-2 study is...

Otsuka Holdings, Otsuka Medical Devices and ReCor Medical to merge

Otsuka Holdings, Otsuka Medical Devices, and ReCor Medical have signed a merger agreement pursuant to which Otsuka Holdings will acquire the remaining shares in...

One in five UK doctors say under staffing has affected patient...

The annual census of UK consultants and higher speciality trainees—Focus on Physicians 2017–18—indicates that more than half of all consultants and two thirds of...

First patient enrolled in Frontier IV clinical trial of PerQseal large...

Vivasure Medical has announced the successful enrolment of the first patient in the Frontier IV clinical study, a non-randomised multicentre international trial, designed to...

First procedure performed in Rox Medical’s CONTROL HTN-2 clinical trial

The first patient was treated in the CONTROL hypertension (HTN)-2 clinical study, the Rox Medical’s pivotal study to evaluate the safety and effectiveness of...

From SYMPLICITY HTN-1 to SPYRAL HTN-OFF MED: The story of renal...

It is now almost a decade since the first patient underwent catheter-based renal denervation as a participant in a safety and proof-of concept study...

ESC 2017: MobiusHD implant shown to reduce resistant hypertension

The European results of the first-in-human trial of Vascular Dynamics’ MobiusHD implant indicate that the device is associated with a reduction in 24-hour ambulatory...

Merit Medical partners with world-renown interventional cardiologist to deliver transradial course

Merit Medical will partner with internationally renowned interventional cardiologist Ferdinand Kiemeneij to deliver the next generation in educational opportunities for interventional cardiologists and interventional...

Terumo to distribute STARSystem for radial access procedures in Europe

STARSystemTerumo Europe has entered into a distribution agreement with New Zealand company Adept Medical to make the STARSystem available to clinicians working across Western...

Endovascular denervation of the coeliac or hypogastric arteries to manage refractory...

Cancer pain matters and it is likely to matter even more in the coming years. Treatment advances have increased life expectancy for cancer patients,...

Terumo’s FineDuo microcatheter receives CE mark

FineDuo—a low profile, multifunctional, dual-lumen microcatheter—now has the CE mark. The device has been developed for use during percutaneous transluminal coronary angioplasty for guidewire...